Validation of a Screening Test for Sarcopenia in Older People (SARCSA)
Primary Purpose
Sarcopenia
Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Handgrip test
Sponsored by
About this trial
This is an interventional prevention trial for Sarcopenia focused on measuring Sarcopenia, Elderly people, Hospitalization
Eligibility Criteria
Inclusion Criteria:
- ≥ 75 years old
Exclusion Criteria:
- Palliative care,
- Protection of vulnerable adults
Sites / Locations
- CHU de Clermont-FerrandRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Older people
Arm Description
A cross-sectional multicentre study will be performed in hospital and retirement houses on patients ages 75 years old or more.
Outcomes
Primary Outcome Measures
Handgrip test could be used as a screening test of sarcopenia
Secondary Outcome Measures
Full Information
NCT ID
NCT03196622
First Posted
June 21, 2017
Last Updated
July 25, 2017
Sponsor
University Hospital, Clermont-Ferrand
Collaborators
Nutriset
1. Study Identification
Unique Protocol Identification Number
NCT03196622
Brief Title
Validation of a Screening Test for Sarcopenia in Older People
Acronym
SARCSA
Official Title
Validation of a Screening Test of Sarcopenia in the Elderly People at Hospital and in Retirement Houses
Study Type
Interventional
2. Study Status
Record Verification Date
June 2017
Overall Recruitment Status
Unknown status
Study Start Date
July 11, 2017 (Actual)
Primary Completion Date
December 2018 (Anticipated)
Study Completion Date
June 2019 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Clermont-Ferrand
Collaborators
Nutriset
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Identify the threshold which the handgrip strenght can be used as a screening test of sarcopenia.
Handgrip strenght can be used in daily clinical practice to screen patients having sarcopenia to improve treatment and quality of life.
Detailed Description
A cross-sectional multicentre study will be performed in hospital and retirement houses on patients ages 75 years old or more.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sarcopenia
Keywords
Sarcopenia, Elderly people, Hospitalization
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Masking Description
Open
Allocation
N/A
Enrollment
1300 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Older people
Arm Type
Experimental
Arm Description
A cross-sectional multicentre study will be performed in hospital and retirement houses on patients ages 75 years old or more.
Intervention Type
Device
Intervention Name(s)
Handgrip test
Intervention Description
Handgrip strenght can be used in daily clinical practice to screen patients having sarcopenia to improve treatment and quality of life.
Primary Outcome Measure Information:
Title
Handgrip test could be used as a screening test of sarcopenia
Time Frame
at day 1
10. Eligibility
Sex
All
Minimum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
≥ 75 years old
Exclusion Criteria:
Palliative care,
Protection of vulnerable adults
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Patrick LACARIN
Phone
04 73 75 11 95
Email
placarin@chu-clermontferrand.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marie BLANQUET
Organizational Affiliation
CHU de Clermont-Ferrand
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU de Clermont-Ferrand
City
Clermont-Ferrand
State/Province
Auvergne
ZIP/Postal Code
63003
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Patrick LACARIN
Phone
04 73 75 11 95
Email
placarin@chu-clermontferrand.fr
First Name & Middle Initial & Last Name & Degree
Marie BLANQUET
12. IPD Sharing Statement
Learn more about this trial
Validation of a Screening Test for Sarcopenia in Older People
We'll reach out to this number within 24 hrs